Results 151 to 160 of about 64,234 (265)

Brunsting-Perry Pemphigoid Confined to the Scalp: A Clinicopathologic Mimicker of Discoid Lupus and Central Centrifugal Cicatricial Alopecia (CCCA). [PDF]

Cureus
Jaffe DS, Alhov N, Van Noord BC, Sobotka M, Kahn B, Louis D, Goodman MB.   +6 more
europepmc   +1 more source

Outcomes of Kaposi sarcoma in people living with HIV who maintain long‐term viral suppression: A prospective case‐series

HIV Medicine, EarlyView.
Abstract Background Data on chemotherapeutic efficacy and tolerability for Kaposi Sarcomas (KS) in people living with HIV (PWH) and HIV‐virological control are limited. We aimed to describe clinical responses and tolerability of KS therapies in PWH with HIV‐aviraemic KS in a prospective cohort.
S. Bacquart, R. Palich, M. Veyri, S. Bregigeon‐Ronot, M.‐C. Picot, C. Vidal, L. Galicier, S. Choquet, J.‐P. Spano, M.‐A. Valantin, A. Makinson   +10 more
wiley   +1 more source

Bosselated scalp nodules with alopecia. [PDF]

JAAD Case Rep
Vilela BF, Martins IA, Cabete J.
europepmc   +1 more source

New insights from data analysis of 12 global clinical studies on hair shedding

International Journal of Cosmetic Science, EarlyView.
Analysis of 12 clinical studies conducted across eight countries indicated that the majority of the hair loss (shedding) originates from the root and occurs throughout the hair care procedures (washing, drying and combing). In females, the ‘older’ group experienced more hair fall than the ‘younger’ group.
Yingjie Li, Shengnan Lin, Sarah Paterson, Tony Dadd, Jiayin Gu, Ranjit K. Bhogal, Zulfa Hudaya, Hepsy Y. Selliah, Mingming Pu, Jianing N. Sun   +9 more
wiley   +1 more source

Effectiveness of the DigniCap® Scalp Cooling System for the Prevention of Chemotherapy-Induced Alopecia: An Observational Study in a Uruguayan Cohort. [PDF]

Cureus
Amarillo D, Camejo N, Castillo C, Planinich M, Garcia M, Insagaray B, Manzanares J, Acevedo B, Benavides S, Manzino J, Muiño P, Servetto G, Guerrina M, Suaya V, Mate C, Latorraca G, Krygier G.   +16 more
europepmc   +1 more source

Prevalence and Risk Factors of Systemic Lupus Erythematosus in Patients With Chronic Cutaneous Lupus: A Bicentric Study Employing Three Classification Criteria

International Journal of Dermatology, EarlyView.
This bicentric study of 95 CCLE patients shows SLE prevalence (21.1%–31.6%) varies significantly by classification criteria. Arthralgia was a consistent independent risk factor across all systems. Our findings support the implementation of systematic risk‐stratified screening protocols for CCLE patients, with particular attention to joint symptoms and ...
Noureddine Litaiem, Syrine Nahali, Maroua Slouma, Mourad Mokni, Faten Zeglaoui   +4 more
wiley   +1 more source

Clinical Characteristics and Factors Associated with Hair Loss Severity in Chronic Hepatitis B Patients Receiving Pegylated Interferon-Alpha: A Retrospective Cohort Study. [PDF]

Clin Cosmet Investig Dermatol
Wang X, Yan Z, Liu C, Gao Y.
europepmc   +1 more source

Early On‐Treatment Change in SALT as a Pragmatic Predictor of Ritlecitinib Response in Moderate‐To‐Severe Alopecia Areata: A Real‐World Cohort Study

International Journal of Dermatology, EarlyView.
Ritlecitinib induced rapid clinical improvement in moderate‐to‐severe alopecia areata in real‐world practice. Early change in SALT at Week 12 strongly discriminated Week‐24 responders, supporting a pragmatic treat‐to‐target checkpoint, alongside improvements in clinician‐reported and patient‐reported outcomes and a favorable safety profile.
Giuseppe Gallo, Isotta Giunipero di Corteranzo, Pietro Quaglino, Simone Ribero, Francois Rosset   +4 more
wiley   +1 more source

Retraction Statement: Paper by Ting Guo, Wenyu Li, and Sijian Wen Entitled "Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study" [Skin Appendage Disord, 2026; DOI: 10.1159/000553570]. [PDF]

Skin Appendage Disord
europepmc   +1 more source

Feasibility of a culturally tailored traction alopecia prevention curriculum in a diverse urban middle school: a pilot study. [PDF]

Int J Womens Dermatol
Afolabi A, Ha EK, Fawole O, Hoffman B, Pugliano-Mauro M.   +4 more
europepmc   +1 more source